MedTech Company BioSig Technologies Deploys Disruptive Technology To Improve Arrhythmia Care

MedTech, HealthTech, Benzinga, BioSig Technologies, BioPharmaceuticals, Jessica Abraham, Jessica N Abraham,

This article was previously published to Benzinga. Arrhythmia is a heart condition that causes it to beat either too fast, or irregularly. It’s triggered by abnormal electrical activity and affects the heart’s rhythm, leading it to beat out of sync with the rest of the body.  Not every patient experiences arrhythmia in the same way, so it’s sometimes necessary for doctors to provide each patient with a personalized approach to treatment and recovery.  Lifestyle choices and comorbidities, […]

Continue Reading

Healthy Hearts and Healthy Wallets: Why one HealthTech Startup is a Must-Invest

Startup, Biotricity, Bioflux, Biokit, Bioheart, Samsung Watch4, Waqaas Al Siddiq

Previously published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Last month, we saw a lot of great startups at the Benzinga Global Small Cap Conference. Many of them screamed, “This is an innovation tech stock you need to buy now!” But given the state of our world at this moment, one startup really stood out. Its key product […]

Continue Reading